The center for breakthrough medicines adopts veeva vault quality suite to help advance cell and gene therapy contract services

Pleasanton, calif., nov. 16, 2021 /prnewswire/ -- veeva systems (nyse: veev) today announced that the center for breakthrough medicines (cbm) adopted veeva vault quality suite to modernize development and manufacturing services for sponsors.
VEEV Ratings Summary
VEEV Quant Ranking